Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-07-11 08:49 am Purchase | 2022-07-08 | 13G | SAGE THERAPEUTICS INC SAGE | FMR LLC | 5,977,093 10.119% | 486,519 (+8.86%) | Filing History |
| 2022-02-11 4:36 pm Purchase | 2021-12-31 | 13G | SAGE THERAPEUTICS INC SAGE | BB BIOTECH AG | 3,170,104 5.400% | 210,000 (+7.09%) | Filing History |
| 2022-02-10 08:37 am Sale | 2021-12-31 | 13G | SAGE THERAPEUTICS INC SAGE | VANGUARD GROUP INC | 4,578,241 7.770% | -20,874 (-0.45%) | Filing History |
| 2022-02-09 10:24 am Sale | 2022-02-08 | 13G | SAGE THERAPEUTICS INC SAGE | FMR LLC | 5,490,574 9.320% | -188,697 (-3.32%) | Filing History |
| 2022-02-04 09:22 am Purchase | 2021-12-31 | 13G | SAGE THERAPEUTICS INC SAGE | WELLINGTON MANAGEMENT GROUP LLP | 7,126,411 12.100% | 999,731 (+16.32%) | Filing History |
| 2021-08-11 5:04 pm Purchase | 2021-08-04 | 13G | SAGE THERAPEUTICS INC SAGE | BB BIOTECH AG | 2,960,104 5.000% | 2,960,104 (New Position) | Filing History |
| 2021-08-10 10:33 am Sale | 2021-08-09 | 13G | SAGE THERAPEUTICS INC SAGE | FMR LLC | 5,679,271 9.711% | -2,127,428 (-27.25%) | Filing History |
| 2021-08-10 07:57 am Purchase | 2021-07-30 | 13G | SAGE THERAPEUTICS INC SAGE | WELLINGTON MANAGEMENT GROUP LLP | 6,126,680 10.480% | 1,843,051 (+43.03%) | Filing History |